Summary
Liza Laws speaks with Nikesh Shah, VP, global head of drug safety and pharmacovigilance, and Dr Siva Kumar Buddha, director of pharmacovigilance and head of signal and risk management at Indegene, on how evolving technologies and methodologies are enhancing the detection, evaluation and management of drug safety signals, ensuring patient safety and regulatory compliance.
Recommended Comments
Create an account or sign in to comment